Methods of treatment using ranolazine and related piperazine derivatives
US5906988A · kind A · utility
20Cited by
1References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 5, 1996 |
| Grant date | May 25, 1999 |
| Priority date | — |
| Expiry date | Apr 5, 2016 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Piperazine derivatives, particularly ranolazine, are useful for treatment of tissues experiencing a physical or chemical insult, and specifically for treating cardioplegia, hypoxic and/or reperfusion injury to cardiac or skeletal muscle or brain tissue, and for use in transplants.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.